text.skipToContent text.skipToNavigation

{{ addToCartData.mixPtRmWarning }}

Do you want to proceed?

{{requestQuote.productName}}; {{requestQuote.displayProductCode}}

Thank you

We will respond to your enquiry shortly.

Something went wrong, please try again later.

Quick Order
If not, click 'cancel'. You can also save this item for later.
Cancel

{{ favouriteItem.successMessage }}

View favourites

Product removed from your favourites

{{ addToCartData.mixPtRmWarning }}

Do you want to proceed?

{{requestQuote.productName}}; {{requestQuote.displayProductCode}}

Thank you

We will respond to your enquiry shortly.

Something went wrong, please try again later.

Product Overview

Documentation

Where shall we send your requested SDS?
Part number:  {{ sdsPopupData.packSize.code }}

{{ errors[0] }}

{{ errors[0] }}

LGC will use your email address only for the purposes of providing the requested document.
For information about our data processing activities, please visit our Privacy Notice.
Thank you

Your request has been sent to our sales team to process.

Product Information

Darunavir is a second generation HIV-1 and HCV protease inhibitor; structurally similar to amprenavir. It is an antiviral that has a high genetic barrier to resistance. Across a diverse population of HIV-1-infected subjects treated with darunavir 800 mg QD regimens, the development of darunavir resistance was rare (<0.1%).

 

References

[1] Koh, Y., et al.: Antimicrob. Agents Chemother., 47, 3123 (2003).

[2] Arasteh, K., et al.: AIDS, 19, 943 (2005).

[3] Surleraux, D.L.N.G., et al.: J. Med. Chem., 48, 1813 (2005) [4] Lathouwers, E., Wong, E., Luo, D., Seyedkazemi, S., De Meyer, S. and Brown, K. (2017) 'HIV-1 resistance rarely observed in subjects using darunavir once-daily regimens across clinical studies', HIV Clinical Trials, 18(5-6), pp. 196-204.

Analyte Name

Darunavir

CAS Number

206361-99-1

Molecular Formula

C27 H37 N3 O7 S

Molecular Weight

547.66

Accurate Mass

547.2352

Flash Point

0

SMILES

CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]2CO[C@H]3OCC[C@@H]23)S(=O)(=O)c4ccc(N)cc4

InChI

InChI=1S/C27H37N3O7S/c1-18(2)15-30(38(33,34)21-10-8-20(28)9-11-21)16-24(31)23(14-19-6-4-3-5-7-19)29-27(32)37-25-17-36-26-22(25)12-13-35-26/h3-11,18,22-26,31H,12-17,28H2,1-2H3,(H,29,32)/t22-,23-,24+,25-,26+/m0/s1

IUPAC

[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate

Storage Temperature

-20°C

Shipping Temperature

Room Temperature

Country of Origin

CANADA

Product Type

Impurity; API

Product Format

Neat

API Family

Darunavir

Purity

>95% (HPLC)

Punchout session timeout warning

Your punchout session will expire in 1 min 59 sec.

Select "Continue session" to extend your session.